Flex And Oncology Clinical Research Private Limited, a active private limited company, was established on 04 July 2019 in Thiruvananthapuram, Kerala, India. Engaging in medical transcription within the professional, scientific and technical sector, it holds CIN: U72900KL2019PTC058663. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹10.00 K and a paid-up capital of ₹10.00 K .
Employing 126 professional, Its leadership includes Sindhu Bhaskaran Pillai (Director), Patricia Bronke Mcnamara (Additional Director). Past directors included Anoop Parameswarakurup Ambika. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Module No 242-243, 2Nd Floor Nila Building , Phase-1 Campus,Technopark, Trivandrum, Thiruvananthapuram, Kerala, 695581.
U72900KL2019PTC058663
058663
04 July 2019
₹10.00 K
₹10.00 K
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Flex And Oncology Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sindhu Bhaskaran Pillai | Director | 04 Jul 2019 | Current |
| Patricia Bronke Mcnamara | Additional Director | 28 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jan 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Flex And Oncology Clinical Research Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 77.78% increase. The company also saw a substantial improvement in profitability, with a 302.06% increase in profit. The company's net worth Soared by an impressive increase of 119.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Flex And Oncology Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Flex And Oncology Clinical Research has a workforce of 126 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Flex And Oncology Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flex And Oncology Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Patricia Bronke Mcnamara was appointed as a Additional Director was appointed as a Additional Director on 28 Oct 2024 & has been associated with this company since 1 year 1 month . was documented.
The activity Flex And Oncology Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Flex And Oncology Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on Sindhu Bhaskaran Pillai was appointed as a Director was appointed as a Director on 04 Jul 2019 & has been associated with this company since 6 years 5 months . was documented.
The activity Flex And Oncology Clinical Research Private Limited was registered on 04 Jul 2019 with Roc Ernakulam & aged 6 years 5 months as per MCA records. was completed.
The CIN of Flex And Oncology Clinical Research Private Limited is U72900KL2019PTC058663.
Flex And Oncology Clinical Research Private Limited is headquartered at Module No 242-243, 2Nd Floor Nila Building , Phase-1 Campus,Technopark, Trivandrum, Thiruvananthapuram, Kerala, 695581.
Flex And Oncology Clinical Research Private Limited was incorporated on 04 July 2019.
The current directors of Flex And Oncology Clinical Research Private Limited are
The primary industry of Flex And Oncology Clinical Research Private Limited is Professional, Scientific And Technical.
Flex And Oncology Clinical Research Private Limited is unlisted.
The authorized capital of Flex And Oncology Clinical Research Private Limited is ₹10.00 K , and the paid-up capital is ₹10.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX